Media thread, page-338

Just spoke with Paul. He just got back from The US. Conversation went well. We spoke at length about Cellgro, BH and Ace Southern, ATI and the collagen rope.

While BH and Ace are under the HS umbrella, both target different market segments with BH providing to individual clientele and ACE tackling the larger hospital/Cinical markets. I asked if there was any overlap and though he said there would probably be a few, but they predominantly hit different companies hence the reason for HS's diversification among its subsidiaries.

Am at work atm and have to jet, but will replay later tonight with more info once i check my notes. He was very jubilant and mentioned the next 4c will show decent growth.

We chated about the SP being garbage and he mentioned how only through increasing revenue will the market finally reward us appropriately, which he feels supremely confident in it doing.

Chat more later.